Hengan FY2025 attributable profit rose 10.3% to RMB2.54 billion

Reuters03-17
Hengan FY2025 attributable profit rose 10.3% to RMB2.54 billion

Hengan published an annual results announcement for FY 2025, reporting revenue up 1.8% to RMB23.07 billion and operating profit up 3.9% to RMB3.48 billion. Profit attributable to shareholders rose 10.3% to RMB2.54 billion, while basic earnings per share increased 10.5% to RMB2.227. Gross profit margin improved to 33.8% from 32.3%, as tissue paper sales growth and lower tissue promotional spending helped offset hygiene product price competition and related promotional expenses. By segment, tissue paper products revenue rose 5.6% to RMB14.17 billion, while hygiene products revenue fell 5.3% to RMB6.57 billion amid aggressive promotions by domestic brands, particularly online. The board proposed a final dividend of RMB0.70 per share, taking the FY 2025 total dividend to RMB1.40 per share.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hengan International Group Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260317-12054790), on March 17, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment